合用双硫仑显著增加氯氮平的血清水平：两例报告。

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.

机构信息

Department of Psychiatry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Department of Psychiatry, Tampere University Hospital, Tampere, Finland.

出版信息

J Psychopharmacol. 2023 Feb;37(2):229-233. doi: 10.1177/02698811221148611. Epub 2023 Jan 26.

DOI:10.1177/02698811221148611

PMID:36703576

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9912305/

Abstract

BACKGROUND

Alcohol use disorder (AUD) is a significant co-morbidity in patients with schizophrenia. Clozapine offers some benefits in treating patients with refractory schizophrenia and AUD, but co-medicating with disulfiram is also common.

PROCEDURES

We report two cases where co-medicating with disulfiram led to a significant increase in clozapine serum levels.

FINDINGS

Clozapine serum levels decreased to one-third in Patient 1 when disulfiram was discontinued and started to increase again when disulfiram was reintroduced. Patient 2 developed toxic serum levels of clozapine during disulfiram treatment combined with heavy coffee drinking and symptoms reminiscent of neuroleptic malignant syndrome.

CONCLUSIONS

Clozapine and disulfiram are both metabolized by cytochrome P450 CYP1A2 and clinically relevant interaction through this shared pathway is possible.

摘要

背景

酒精使用障碍（AUD）是精神分裂症患者的一种严重共病。氯氮平在治疗难治性精神分裂症和 AUD 患者方面具有一定优势，但也常与双硫仑联合用药。

方法

我们报告了两例因联合使用双硫仑导致氯氮平血药浓度显著升高的病例。

结果

停用双硫仑后，患者 1 的氯氮平血药浓度降至三分之一，再次使用双硫仑时又开始升高。患者 2 在双硫仑治疗期间合并大量饮用咖啡，并出现类神经阻滞剂恶性综合征的症状，导致氯氮平血药浓度中毒。

结论

氯氮平和双硫仑均通过细胞色素 P450 CYP1A2 代谢，通过这种共同途径可能存在临床相关的相互作用。

相似文献

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.

J Psychopharmacol. 2023 Feb;37(2):229-233. doi: 10.1177/02698811221148611. Epub 2023 Jan 26.

Short-term use of disulfiram with clozapine.

J Clin Psychopharmacol. 1994 Jun;14(3):213-5.

Substance abuse and schizophrenia: pharmacotherapeutic intervention.

J Subst Abuse Treat. 2008 Jan;34(1):61-71. doi: 10.1016/j.jsat.2007.01.008. Epub 2007 Jun 15.

Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):984-8. doi: 10.1016/j.pnpbp.2008.01.009. Epub 2008 Jan 18.

Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?

J Psychopharmacol. 2005 May;19(3):301-5. doi: 10.1177/0269881105051542.

Omeprazole reduces clozapine plasma concentrations. A case report.

Pharmacopsychiatry. 2003 May;36(3):121-3. doi: 10.1055/s-2003-39980.

Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.

Psychiatry Res. 2012 Dec 30;200(2-3):1014-7. doi: 10.1016/j.psychres.2012.07.002. Epub 2012 Aug 16.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7.

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

Schizophr Bull. 2000;26(2):441-9. doi: 10.1093/oxfordjournals.schbul.a033464.

Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.

Pharmacogenomics J. 2020 Apr;20(2):192-201. doi: 10.1038/s41397-019-0108-y. Epub 2019 Oct 15.

引用本文的文献

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.

J Clin Psychopharmacol. 2025;45(3):179-196. doi: 10.1097/JCP.0000000000001987. Epub 2025 Apr 9.

Evaluation of major adverse events of clozapine based on accordance to an international titration guideline.

Ment Health Clin. 2024 Jun 3;14(3):204-211. doi: 10.9740/mhc.2024.06.204. eCollection 2024 Jun.

本文引用的文献

Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.

BMC Psychiatry. 2021 Apr 13;21(1):192. doi: 10.1186/s12888-021-03199-x.

Morbidity and mortality in schizophrenia with comorbid substance use disorders.

Acta Psychiatr Scand. 2021 Jul;144(1):42-49. doi: 10.1111/acps.13291. Epub 2021 Mar 8.

Is there a future for pharmacogenetics in the optimal dosing of clozapine?

Pharmacogenomics. 2020 Apr;21(6):369-373. doi: 10.2217/pgs-2020-0015. Epub 2020 Apr 20.

A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.

Psychother Psychosom. 2020;89(4):200-214. doi: 10.1159/000507638. Epub 2020 Apr 14.

Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia.

J Clin Psychiatry. 2019 Mar 5;80(2):18com12123. doi: 10.4088/JCP.18com12123.

Elevated clozapine levels associated with infection: A systematic review.

Schizophr Res. 2018 Feb;192:50-56. doi: 10.1016/j.schres.2017.03.045. Epub 2017 Apr 6.

Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders.

Curr Addict Rep. 2014 Dec;1(4):251-260. doi: 10.1007/s40429-014-0034-7. Epub 2014 Sep 27.

A case of clozapine intoxication presenting with atypical NMS symptoms.

Int J Neuropsychopharmacol. 2014 May;17(5):819-21. doi: 10.1017/S1461145713001624. Epub 2014 Jan 17.

Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.

Pharmacogenet Genomics. 2013 May;23(5):279-85. doi: 10.1097/FPC.0b013e3283602876.

It's a typical case of clozapine toxicity.

Aust N Z J Psychiatry. 2012 Oct;46(10):1008. doi: 10.1177/0004867412446490.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

合用双硫仑显著增加氯氮平的血清水平：两例报告。

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.

机构信息

Department of Psychiatry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Department of Psychiatry, Tampere University Hospital, Tampere, Finland.

出版信息

J Psychopharmacol. 2023 Feb;37(2):229-233. doi: 10.1177/02698811221148611. Epub 2023 Jan 26.

DOI:10.1177/02698811221148611

PMID:36703576

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9912305/

Abstract

BACKGROUND

PROCEDURES

We report two cases where co-medicating with disulfiram led to a significant increase in clozapine serum levels.

FINDINGS

CONCLUSIONS

Clozapine and disulfiram are both metabolized by cytochrome P450 CYP1A2 and clinically relevant interaction through this shared pathway is possible.

摘要

背景

酒精使用障碍（AUD）是精神分裂症患者的一种严重共病。氯氮平在治疗难治性精神分裂症和 AUD 患者方面具有一定优势，但也常与双硫仑联合用药。

方法

我们报告了两例因联合使用双硫仑导致氯氮平血药浓度显著升高的病例。

结果

结论

氯氮平和双硫仑均通过细胞色素 P450 CYP1A2 代谢，通过这种共同途径可能存在临床相关的相互作用。

合用双硫仑显著增加氯氮平的血清水平：两例报告。

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.

机构信息

出版信息

BACKGROUND

PROCEDURES

FINDINGS

CONCLUSIONS

背景

方法

结果

结论

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

合用双硫仑显著增加氯氮平的血清水平：两例报告。

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.

机构信息

出版信息

BACKGROUND

PROCEDURES

FINDINGS

CONCLUSIONS

背景

方法

结果

结论